Centene Raises Profit Forecast on Cost Control Success

Centene announced on Tuesday that it has raised its annual forecast for adjusted profit and revenue, exceeding expectations after a solid first-quarter performance. The health insurer attributes this positive outlook to successful efforts in managing elevated costs and achieving margin recovery.

The company reported a medical loss ratio of 87.3% for the first quarter, which was notably lower than the 89.42% anticipated by analysts. This improvement was bolstered by effective management of general medical costs and moderate flu-related expenses.

However, Centene did note a slight increase in costs within its Obamacare silver tier plans. This was driven by a higher number of sick patients and increased demand for specialty pharmacy services among members who have lower out-of-pocket expenses due to their higher premiums.

Centene now projects its 2026 adjusted profit to be above $3.40 per share, an increase from its previous forecast of over $3.00. The company also revised its full-year revenue forecast upwards to between $187.5 billion and $191.5 billion. These projections follow similar upward revisions from major competitors UnitedHealth and Elevance, indicating a potentially stabilizing period for the healthcare sector after a prolonged period of rising medical costs.